title: A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma.
authors.affiliation: a Department of Medical Oncology , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Tokyo , Japan ;
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Kanemasa
authors.affiliation: a Department of Medical Oncology , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Tokyo , Japan ;
authors.forename: Tatsu
authors.initials: T
authors.lastname: Shimoyama
authors.affiliation: b Department of Clinical Research Support , Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo , Japan ;
authors.forename: Yuki
authors.initials: Y
authors.lastname: Sasaki
authors.affiliation: a Department of Medical Oncology , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Tokyo , Japan ;
authors.forename: Takeshi
authors.initials: T
authors.lastname: Sawada
authors.affiliation: a Department of Medical Oncology , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Tokyo , Japan ;
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Omuro
authors.affiliation: c Department of Pathology , Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo , Japan.
authors.forename: Tsunekazu
authors.initials: T
authors.lastname: Hishima
authors.affiliation: a Department of Medical Oncology , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Tokyo , Japan ;
authors.forename: Yoshiharu
authors.initials: Y
authors.lastname: Maeda
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000418:Albumins / Q000032:analysis; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols; D002097:C-Reactive Protein / Q000032:analysis; D003520:Cyclophosphamide; D004317:Doxorubicin; D005260:Female; D006801:Humans; D045022:Lactate Dehydrogenases / Q000097:blood*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality; D008297:Male; D008875:Middle Aged; D063868:Patient Outcome Assessment; D011237:Predictive Value of Tests; D011241:Prednisone; D011379:Prognosis; D012107:Research Design; D000069283:Rituximab; D016019:Survival Analysis; D014750:Vincristine
chemical_list: D000418:Albumins; D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002097:C-Reactive Protein; D045022:Lactate Dehydrogenases; D011241:Prednisone